Europe dithers over stem cell patents

Mitchell, Peter
February 2003
Nature Medicine;Feb2003, Vol. 9 Issue 2, p154
Academic Journal
Reports plans of the European Commission to restrict the scope of stem cell technology patents. Development of stem cell-based therapeutics; Assessment of the patentability of biotechnology-based inventions; Ethics of stem cell research.


Related Articles

  • Patents for Human Embryonic Stem Cells? Carlin, Robert // Medical Device Technology;Jun2003, Vol. 14 Issue 5, p16 

    Focuses on the patentability of human embryonic stem cells in Great Britain. Definition of stem cells; Processes for obtaining stem cells; Potential of totipotent cell; Commercial exploitation of inventions concerning human embryonic pluripotent stem cells.

  • Recent patents in stem cell research.  // Nature Biotechnology;Apr99, Vol. 17 Issue 4, p396 

    Presents information on patents on stem cell research. Subject of the research; Name of assignee; Status.

  • Patent Watch.  // Nature Reviews Drug Discovery;Oct2003, Vol. 2 Issue 10, p766 

    Reports on rules for stem cell patents in Great Britain. Patentability of inventions involving human embryonic cells.

  • US company comes under fire over patent on umbilical cord cells. Butler, Declan // Nature;7/11/1996, Vol. 382 Issue 6587, p99 

    Reports that research groups are planning to challenge a European patent on the use stored stem cells from umbilical cord blood granted to the Biocyte Corp. Moral issue of patenting a human tissue.

  • Say no to stem cell patents. Coghlan, Andy // New Scientist;5/18/2002, Vol. 174 Issue 2343, p5 

    Reports the stand of the European Group on Ethics in Science and New Technologies regarding the patenting of undifferentiated stem cells. Favor on the creation of an European-wide bank of unmodififed stem cells; Influence on the type of stem cell patent applications granted by the European...

  • Patent Watch.  // Cells Tissues Organs;2007, Vol. 186 Issue 2, p154 

    A list of patents related to cells, organs and tissues is presented. They include Engineering Three-Dimensional Tissue Structures Using Differentiating Embryonic Stem Cells, Natural Tissue-Derived Decellularized Matrix and Methods of Generating and Using Same, and Method of Isolating Human...

  • Patent watch.  // Nature Reviews Drug Discovery;Oct2002, Vol. 1 Issue 10, p750 

    Reports on developments concerning patents in Europe and the United States as of October 2002. Oral proceedings of the Opposition Division of the European Patent Office concerning the use of genetic engineering to isolate stem cells from more differentiated cells to obtain pure stem-cell...

  • Opponents of stem-cell patent win restrictions. Abbott, Alison; Schmidt, Oliver // Nature;8/1/2002, Vol. 418 Issue 6897, p470 

    Reports on the restriction in the scope of patent covering technologies for purifying human and animal embryonic stem cells by the European Patent Office in 2002. Details of the patent coverage; Groups that filed objections to the patent; Claim against the methods involved in the patent; Basis...

  • Patent truce.  // New Scientist;2/5/2011, Vol. 209 Issue 2798, p4 

    The article focuses on an international pact to prevent lengthy patent disputes concerning induced pluripotent stem cells, with patents owned by Kyoto University in Japan and biopharmaceutical company iPierian being pooled to avoid disputes that would hinder the creation of medical treatments...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics